Oculis Holding AG Secures USD 110 Million Through Share Offerings

VISCHER AG has advised Oculis Holding AG. Oculis Holding AG, a global biopharmaceutical company listed on Nasdaq and XICE, has announced the successful pricing of offerings…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here